logo
Uncertain times for research on hemophilia and allied disorders
Coley's toxin revisited
Antithrombotic strategies for atrial fibrillation
Antithrombotic strategies for atrial fibrillation
Factor Xa inhibitors in acute coronary syndromes
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes
One more way that mice and men are different
Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor
Asymptomatic thrombophilia—a family affair
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
Vessel wall apoptosis and atherosclerotic plaque instability
Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins
Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients
Insertion of a C in the exon 28 of integrin αIIb gene leading to a frameshift mutation is responsible for Glanzmann thrombasthenia in a Japanese case
Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications
Thrombophilic risk factors in patients with severe carotid atherosclerosis
The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism
In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor
Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?
The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury
Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event
The von Willebrand factor self-association is modulated by a multiple domain interaction
Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress
Laboratory monitoring of low-molecular-weight heparin therapy—part II
Laboratory monitoring of low-molecular-weight heparin therapy—part II
Laboratory monitoring of low-molecular-weight heparin therapy—part II
Laboratory monitoring of low-molecular-weight heparin therapy—part II
Hypercoagulability preceding cancer
Hypercoagulability preceding cancer
Hypercoagulability preceding cancer
Hypercoagulability preceding cancer
Hypercoagulability preceding cancer
Mechanisms for acquired activated protein C resistance in cancer patients
Diagnosis of deep venous thrombosis and pulmonary embolus in patients with mucinous variant adenocarcinoma
Application of pulmonary embolism rule-out criteria to the UK Manchester Investigation of Pulmonary Embolism Diagnosis (MIOPED) study cohort
Homozygous type I Protein C deficiency in neonatal purpura fulminans with a novel frame-shift deletion of 10 base pairs in exon 8 of PROC gene
Treatment of patients with acquired inhibitors
The 46C→T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis
Should we screen Eastern Mediterranean sickle beta-thalassemia patients for inherited thrombophilia?
A novel fibrinogen γ chain mutation (γ 239 Gln→His) is the cause of dysfibrinogenemia Vicenza
Macrothrombocytopenia in velocardiofacial syndrome
The biphasic waveform in plasma
The biphasic waveform in plasma
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery
More on
More on
More on
More on
More on
Talking about …
ANNOUNCEMENTS
Erratum
Corrigenda